Change in N-terminal pro-B-type natriuretic peptide at 1 year predicts mortality in wild-type transthyretin amyloid cardiomyopathy.

Steven LawAviva PetrieLiza ChackoOliver C CohenSriram RavichandranJanet A GilbertsonDorota RowczenioAshutosh D WechalekarAna Martinez-NaharroHelen J LachmannCarol J WhelanDavid F HuttPhilip N HawkinsMarianna FontanaJulian D Gillmore

Published in: Heart (British Cardiac Society) (2021)

Change in NT-proBNP concentration during the first year of follow-up is a powerful independent predictor of mortality in wtATTR-CM.

Keyphrases

wild type
cardiovascular events
heart failure
risk factors
cardiovascular disease
type diabetes